Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus
  • PFAS in Water
  • Tear Gas and ICE Raids

WHAT'S NEW

  • TrumpRx
  • Pharmacy Discount Coupons
  • Hantavirus
  • PFAS in Water
  • Tear Gas and ICE Raids

KHN Weekly Edition: July 2, 2021

  • Email

Friday, Jul 2 2021

Unprecedented Lobbying Effort Scores Big Win for California Public Health

Angela Hart

After years of unstable funding, California’s 2022-23 budget will include a dramatic new investment in public health. Insiders say a powerhouse lobbying campaign made all the difference.

California Lawmakers Push Feds to Allow a Therapy That Pays Meth Users to Abstain

Mark Kreidler

The approach, known as contingency management, has helped thousands of veterans kick the methedrine habit, but a federal government ruling has limited its use. California hopes to challenge that and make the treatment a Medi-Cal benefit.

Hospital Prices Must Now Be Transparent. For Many Consumers, They’re Still Anyone’s Guess.

Julie Appleby

A Trump administration rule mandating that hospitals disclose true prices on their websites took effect this year. But compliance is spotty and even when the data is public, it’s hard to find and understand.

How One Rural Town Without a Pharmacy Is Crowdsourcing to Get Meds

Markian Hawryluk

As more independently owned community pharmacies close, a Colorado town is crowdsourcing ways of getting prescription medicines delivered to those who can’t travel the long distance to the closest pharmacy. But even those stopgap measures don’t always work.

Damage to Children’s Education — And Their Health — Could Last a Lifetime

Liz Szabo

Black and Hispanic students have lost up to 12 months of learning, which could lead to lower incomes and shorter, sicker lives.

Desperate for Home Care, Seniors Often Wait Months With Workers in Short Supply

Phil Galewitz

The covid pandemic and President Joe Biden's agenda — a planned $400 billion infusion of support — have focused national attention on the need to expand home- and community-based long-term care services designed to keep people out of nursing homes. But the need far outpaces the staffing.

States Step Up Push to Regulate Pharmacy Drug Brokers

Katheryn Houghton

In an ongoing effort to control prescription drug costs, states are targeting the companies that mediate deals among drug manufacturers, health insurers and pharmacies. The pharmacy benefit managers say they negotiate lower prices for patients, yet the nitty-gritty occurs largely behind a curtain that lawmakers are trying to pull back.

Without Enough Boots on the Ground, California’s Vaccination Efforts Falter

Angela Hart

California’s vaccination rates have stagnated, particularly in Black and Latino inner-city neighborhoods and in rural towns. County health officials, who say trust is their most important commodity, need more money for one-on-one interactions with holdouts, but the state has instead largely funneled money to advertising firms and tech companies.

Analysis: Why We’ll Likely Never Know Whether a Covid Lab Leak Happened in China

Elisabeth Rosenthal

If international scientific sleuths are hoping to see a lab log or find a whistleblower, that sort of information won’t be revealed. In China today, it is dangerous to say what you know if it challenges the official government narrative.

Covid’s Lingering Effects Can Put the Brakes on Elective Surgeries

Michelle Andrews

Even after recovering from covid, many patients experience respiratory or other problems and, since this effect of the virus is so unpredictable, medical experts aren't sure when it is safe to undergo elective surgery. But medical experts are setting up guidelines.

Doctors’ Lobby Scores ‘Major Victory’ on Bill to Hold Physicians Accountable

Samantha Young

Patients and some lawmakers have long blasted the Medical Board of California for failing to discipline negligent or abusive physicians. But the politically powerful California Medical Association, which represents doctors, has mobilized against the latest attempt to give the board more money and power to investigate complaints.

A Hospital Charged $722.50 to Push Medicine Through an IV. Twice.

Rae Ellen Bichell

A college student never got an answer for what caused her intense pain, but she did get a bill that totaled $18,736 for an ER visit. She and her mom, a nurse practitioner, fought to understand all the charges.

Children and Covid: Journalists Explore Grief and Vaccine Side Effects

KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.

KHN’s ‘What the Health?’: Un-Trumping the ACA

The Biden administration is moving to undo many of the changes the Trump administration made to the enrollment process for the Affordable Care Act to encourage more people to sign up for health insurance. Meanwhile, Congress is opening investigations into the controversial approval by the Food and Drug Administration of an expensive drug that might (or might not) slow the progression of Alzheimer’s disease. Joanne Kenen of Politico, Kimberly Leonard of Insider and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews Marshall Allen of ProPublica about his new book, “Never Pay the First Bill: And Other Ways to Fight the Health Care System and Win.”

Recent Newsletters

  • The Week in Brief: Friday, May 7, 2026
  • The Week in Brief: Friday, May 1, 2026
  • Colorado Checkup: April 29, 2026
  • Rural Dispatch: Tuesday, April 28, 2026
  • The Week in Brief: Friday, April 24, 2026
  • The Week in Brief: Friday, April 17, 2026
More Newsletters
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF